Engineered Toll-like Receptor Nanoagonist Binding to Extracellular Matrix Elicits Safe and Robust Antitumor Immunity
ACS Nano · 2023
DOI: 10.1021/acsnano.2c08429 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, 2023. Verfasst von Liu Yang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Jinling Hospital, Medical School of Nanjing University, Nanjing, 210002 Jiangsu, China. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Ministry of Science and Technology of the People's Republic of China, National Medical Research Council, Natural Science Foundation of Jiangsu Province.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Jinling Hospital, Medical School of Nanjing University, Nanjing, 210002 Jiangsu, China.
- National Clinical Research Center of Kidney Diseases, Jinling Hospital, Medical School of Nanjing University, Nanjing, 210002 Jiangsu, China.
- Department of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore.
- Nanomedicine Translational Research Program, NUS Center for Nanomedicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore.
- School of Medicine and Health, Harbin Institute of Technology, Harbin 150080, China.
- Clinical Imaging Research Centre, Centre for Translational Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117599, Singapore.
ORCID-Profile: Liangcan He, Guangming Lu, Xiaoyuan Chen
Förderung
- Ministry of Science and Technology of the People's Republic of China
- National Medical Research Council
- Natural Science Foundation of Jiangsu Province
- National University of Singapore
- National Natural Science Foundation of China
Zitieren
APA
Yang, L., Lang, Y., Wu, H., Xiang, K., Wang, Y., Yu, M., Liu, Y., Yang, B., He, L., Lu, G., Ni, Q., Chen, X., & Zhang, L. (2023). Engineered Toll-like Receptor Nanoagonist Binding to Extracellular Matrix Elicits Safe and Robust Antitumor Immunity. ACS Nano. https://doi.org/10.1021/acsnano.2c08429
Vancouver
Yang L, Lang Y, Wu H, Xiang K, Wang Y, Yu M, et al. Engineered Toll-like Receptor Nanoagonist Binding to Extracellular Matrix Elicits Safe and Robust Antitumor Immunity. ACS Nano. 2023. doi:10.1021/acsnano.2c08429
BibTeX
@article{Yang2023,
author = {Yang, Liu and Lang, Yue and Wu, Haoguang and Xiang, Kaiyan and Wang, Yuanzheng and Yu, Mengqi and Liu, Yu and Yang, Bowei and He, Liangcan and Lu, Guangming and Ni, Qianqian and Chen, Xiaoyuan and Zhang, Longjiang},
title = {Engineered Toll-like Receptor Nanoagonist Binding to Extracellular Matrix Elicits Safe and Robust Antitumor Immunity},
journal = {ACS Nano},
year = {2023},
doi = {10.1021/acsnano.2c08429}
}
EUVIMED